Wegovy, weight loss
Most people quit Wegovy, Saxenda before they see weight loss benefits
A report by Blue Shield notes that more than half of people on weight loss medications such as Wegovy and Saxenda stop taking the drugs before they can reap the benefits
Use of Wegovy and other weight-loss drugs soars among kids and young adults
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.
Use of weight-loss drugs Wegovy and Ozempic climbs among children
The use of weight-loss drugs such as Wegovy and Ozempic has climbed among children in the United States, according to a study released Wednesday. The study, published in the Journal of the American Medical Association,
Wegovy, Saxenda study reveals surprising trend for weight loss drugs
Nearly 1 in 3 patients halted treatment within four weeks, before the recommended dosage reached the drugs' targeted strength. Because these patients dropped out before completing the recommended treatment,
Hims & Hers Selling GLP-1 Weight Loss Drugs Like Wegovy for 85% Less: What to Know
Telehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to Ozempic and Wegovy at a significantly lower price. Here's how.
Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy
Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.
6 types of foods and drinks to avoid when taking Ozempic or Wegovy for weight loss
Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the side effects, doctors say.
Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds
Key Takeaways New research shows that a sizable minority of folks who start Wegovy or other weight-loss meds quit within a few months of use Half of users who are obese but not diabetic quit the meds by the one-year mark Cost and side effects appeared to be key factors THURSDAY,
Nestlé is releasing a lineup of frozen food for people on Ozempic, Wegovy and other GLP-1 drugs
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people ...
Verywell Health on MSN1d
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 Years and Support Heart Health
A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four ...
STAT17h
Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy
If Regeneron or other companies succeed in developing RNA-based obesity drugs, it would be a significant shift away from ...
Nestlé to debut Vital Pursuit healthy food brand for Ozempic, Wegovy medication users
Nestlé is launching Vital Pursuit, a new line food meant to support Americans who use weight management medications like ...
Ozempic, Wegovy linked to cases of stomach paralysis, new research shows
New research this month is the latest to link the use of Ozempic, Wegovy, and other GLP-1 drugs to a greater risk of ...
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
Not all of it is positive, as revealed by a new study conducted by Blue Health Intelligence that examined 170,000 GLP-1 users ...
Celebrity chef rails against frozen meals for Ozempic and Wegovy users: ‘Messed up as it gets’
The irony of processed food companies coming out with frozen meals for Ozempic and Wegovy users isn’t lost on Chef Andrew ...
Medical Xpress on MSN1d
Young people are increasingly using Wegovy and Ozempic, study finds
Public interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the ...